Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

IGC Pharma, Inc. Common Stock (NY:IGC)

0.4153 -0.0184 (-4.24%)
Official Closing Price Updated: 4:00 PM EDT, Sep 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 977,275
Open 0.4329
Bid (Size) 0.4122 (5)
Ask (Size) 0.4238 (1)
Prev. Close 0.4337
Today's Range 0.3900 - 0.4353
52wk Range 0.2525 - 0.4985
Shares Outstanding 49,784,017
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
IGC Pharma Expands CALMA Phase 2 Trial to Island Health's Royal Jubilee Hospital in Canada
Via ACCESS Newswire
Top movers in Thursday's after hours session
Let's have a look at what is happening on the US markets after the closing bell on Thursday. Below you can find the top gainers and losers in today's after hours session. 
Via Chartmill

Performance

YTD
+16.3%
+16.3%
1 Month
+22.3%
+22.3%
3 Month
+32.3%
+32.3%
6 Month
+27.3%
+27.3%
1 Year
+12.0%
+12.0%

More News

Read More
IGC Pharma receives Notice of Allowance for Novel THC Microdose-Based Treatment for Stammering, Stuttering, and Tourette's Syndrome
Via ACCESS Newswire
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Insights Ahead: IGC Pharma's Quarterly Earnings
Via Benzinga
IGC Pharma Announces Coverage Report by Ascendiant Capital Markets about the "Reports Q1 results. We believe more positive clinical data and progress in 2025 to be strong catalysts for stock. Raising P/T to $4.50."
Via ACCESS Newswire
IGC Pharma Expands CALMA Phase 2 Trial with Site at Lynn Health Science Institute in Oklahoma City
Via ACCESS Newswire
IGC Pharma Reports First Quarter Fiscal 2026 Financial Results; Company Accelerates Phase 2 Alzheimer's Trial
Via ACCESS Newswire
IGC Pharma Highlights Alzheimer's Pipeline with Encouraging Preclinical Data on IGC-M3 and Advancing Phase 2 Cannabinoid-Based IGC-AD1
Via ACCESS Newswire
IGC Pharma Reports IGC-M3's In Vitro Efficacy Against Alzheimer's - Targeting key Drivers of Disease Progression
Via ACCESS Newswire
IGC Pharma to Present Advanced AI Platforms for Alzheimer's Disease at the AAIC 2025
Via ACCESS Newswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
IGC Pharma's Principal Scientist Dr. Jagadeesh Rao Receives Best Researcher Award at 11th Annual World Neuroscience Awards
Via ACCESS Newswire
The trading volume of these stocks is deviating from the norm in today's session.
Via Chartmill
IGC Pharma Introduces MINT-AD: Proprietary AI Platform to Predict Alzheimer's Risk and Accelerate Early Detection
Via ACCESS Newswire
In today's session, these stocks are experiencing unusual volume.
Via Chartmill
Get insights into the top gainers and losers of Thursday's pre-market session.
Via Chartmill
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why WK Kellogg Shares Are Trading Higher By Over 50%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Massive 69.4% Surge for IGC Pharma in After-Hours Trading: Here's Why
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
What's going on in today's after hours session
Via Chartmill
IGC Pharma: Fiscal Year 2025 Financial and Operational Highlights - A Year of Transformative Progress in Alzheimer's Innovation
Via ACCESS Newswire
US Stocks Likely To Open Higher, Continuing Record-Setting Advances: June Has Never Seen An All-Time High Since 1950, Highlights Expert
Via Benzinga
Progress Software, Exicure And 3 Stocks To Watch Heading Into Monday
Via Benzinga

Frequently Asked Questions

Is IGC Pharma, Inc. Common Stock publicly traded?
Yes, IGC Pharma, Inc. Common Stock is publicly traded.
What exchange does IGC Pharma, Inc. Common Stock trade on?
IGC Pharma, Inc. Common Stock trades on the New York Stock Exchange
What is the ticker symbol for IGC Pharma, Inc. Common Stock?
The ticker symbol for IGC Pharma, Inc. Common Stock is IGC on the New York Stock Exchange
What is the current price of IGC Pharma, Inc. Common Stock?
The current price of IGC Pharma, Inc. Common Stock is 0.4153
When was IGC Pharma, Inc. Common Stock last traded?
The last trade of IGC Pharma, Inc. Common Stock was at 09/08/25 04:00 PM ET
What is the market capitalization of IGC Pharma, Inc. Common Stock?
The market capitalization of IGC Pharma, Inc. Common Stock is 20.68M
How many shares of IGC Pharma, Inc. Common Stock are outstanding?
IGC Pharma, Inc. Common Stock has 21M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.